Derivation of a reference dose and drinking water equivalent level for 1,2,3-trichloropropane

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1488-1510

  Tardiff, Robert G ^a   Carson, M Leigh ^a  

^a The Sapphire Group Inc   (United States)

Author keywords

Benchmark dose; Cancer; DWEL; Non linear dose response; Reference dose; Trichloropropane

Indexed keywords

1,2,3 TRICHLOROPROPANE; ALKANE DERIVATIVE; DRINKING WATER; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; MALIGNANT NEOPLASTIC DISEASE; MUTAGENICITY; PUBLIC HEALTH SERVICE; REFERENCE VALUE; SAFETY; STANDARDIZATION; WATER CONTAMINATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICE; MONTE CARLO METHOD; MUTAGENS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PROPANE; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

ANIMALIA; MUS; RATTUS; ZEA MAYS;

EID: 77952877714     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.016     Document Type: Article

References (103)

1. Albert D.M., Frayer W.C., Black H.E., Massicotte S.J., Sang D.N., Soque J. The Harderian gland: its tumors and its relevance to humans. Trans. Am. Ophthalmol. Soc. 1986, 84:321-341.
2. American Conference of Industrial Hygienists (ACGIH), 1996. 1,2,3-Trichloropropane. In: Documentation of the Threshold. Limit Values and Biological Exposure Indices, sixth ed. Cincinnati, Ohio.
3. Agency for Toxic Substances and Disease Registry (ATSDR), 1992. Toxicological Profile for 1,2,3-Trichloropropane. US Department of Health and Human Services.
4. Asano N., Torous D.K., Tometsko C.R., Dertinger S.D., Morita T., Hayashi M. Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine. Mutagenesis 2006, 21:15-20.
5. 001 tumor and biomarker study. Chem. Res. Toxicol. 2009, 22:1264-1276.
6. Bikales N.M. Polysulfide polymers. Encyclopedia of Polymer Science and Technology 1969, vol. 11:425. Interscience, New York.
7. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 2006, 36:781-792.
8. Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 2008, 38:87-96.
9. Boysen G., Pachkowski B.F., Nakamura J., Swenberg J.A. The formation and biological significance of N7-guanine adducts. Mutat. Res. 2009, 678:76-94.
10. California Department of Public Health (CDPH), 2007. 1,2,3-Trichloropropane. State of California. <>http://www.cdph.ca.gov/certlic/drinkingwater/Documents/123-TCP/123tcpforweb.XLS.
11. Carere A. Genotoxicity and carcinogenicity of acrylamide: a critical review. Ann. Ist. Super. Sanita 2006, 42:144-155.
12. Clayson D.B., Iverson F., Nera E.A., Lok E. The significance of induced forestomach tumors. Ann. Rev. Toxicol. 1990, 30:441-463.
13. Clewell H.J.I.I.I., Andersen M.E., Barton H.A. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ. Health Perspect. 2002, 110:85-93.
14. Cortopassi G.A., Wang E.A. There is substantial agreement among interspecies estimates of DNA repair activity. Mech. Ageing Dev. 1996, 91:211-218.
15. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 2007, 67:3904-3911.
16. Dutch Expert Committee on Occupational Standards (DECOS), 1998. 1,2,3-Trichloropropane: Evaluation of the Carcinogenicity and Genotoxicity. Health Council of the Netherlands.
17. Dybing E., Sanner T. Risk assessment of acrylamide in foods. Toxicol. Sci. 2003, 75:7-15.
18. Eustis S.L., Boorman G.A. Proliferative lesions of the exocrine pancreas: relationship to corn oil gavage in the National Toxicology Program. J. Natl. Cancer Inst. 1985, 75:1067-1073.
19. Eustis S.L., Boorman G.A. Exocrine pancreas. Pathology of the Fischer Rat: Reference and Atlas 1990, 95-108. Academic Press, New York. G.A. Boorman, S.L. Eustis, M.R. Elwell (Eds.).
20. Favor J. The mutagenic activity of ethylnitrosourea at low doses in spermatogonia of the mouse as assessed by the specific-locus test. Mutat. Res. 1998, 405:221-226.
21. Figge F.J.H., Strong L.C., Shanbrom A. Fluorescent porphyrins in the Harderian glands and susceptibility to spontaneous mammary carcinoma in mice. Cancer Res. 1942, 2:335-342.
22. Friedberg E.C. DNA damage and repair. Nature 2003, 421:436-440.
23. Friedberg E.C., McDaniel L.D., Schultz R.A. The role of endogenous and exogenous DNA damage and mutagenesis. Curr. Opin. Genet. Dev. 2004, 14:5-10.
24. Furihata C., Ohta H., Katsuyama T. Cause and effect between concentration-dependent tissue damage and temporary cell proliferation in rat stomach mucosa by NaCl, a stomach tumor promoter. Carcinogenesis 1996, 17:401-406.
25. Guttenplan J.B. Mutagenesis by N-nitroso compounds: relationships to DNA adducts, DNA repair, and mutational efficiencies. Mutat. Res. 1990, 233:177-187.
26. Hansen, J.F., Ross, P.E., Makovec, G.T., Eustis, S.L., Sigler, R.E. 1995. Proliferative and other selected lesions of the exocrine pancreas in rats, GI-6. In: Society of Toxicologic Pathologists (Ed.), Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC.
27. Hawaii Department of Health (HDOH), 2005. Trace Amounts of Organic Chemicals Found in One Maui Water Well. State of Hawaii.
28. Hawaii Department of Health (HDOH), 2009. Contaminants Regulated by the Safe Drinking Water Branch (Effective 3/4/09). State of Hawaii
29. Hazardous Substance Data Bank (HSDB), 2009. 1,2,3-Trichloropropane. National Library of Medicine (accessed 09.03.09).
30. Health Canada, 1994. Human Health Risk Assessment for Priority Substances. Canadian Environmental Protection Act, Ontario.
31. Irwin R.D., Haseman J.K., Eustis S.L. 1,2,3-Trichloropropane: a multisite carcinogen in rats and mice. Fundam. Appl. Toxicol. 1995, 25:241-252.
32. Ito N., Fukushima S., Imaida K., Sakata T., Masui T. Induction of papilloma in the forestomach of hamsters by butylated hydroxyanisole. Gann 1983, 74:459-461.
33. Ito N., La D.K., Holt S., Craft T.F., Sills R.C., Swenberg J.A. Analysis of ras mutations in forestomach tumors from B6C3F1 mice exposed to 1,2,3-trichloropropane. Proc. Am. Assoc. Cancer Res. 1996, 37:137.
34. Jenkins G.J.S., Doak S.H., Johnson G.E., Quick E., Waters E.M., Parry J.M. Do does response thresholds exist for genotoxic alkylating agents?. Mutagenesis 2005, 20:389-398.
35. Ji B., Bi Y., Simeone D., Mortensen R.M., Logsdon C.D. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 2001, 121:1380-1390.
36. Johnson G.E., Doak S.H., Griffiths S.M., Quick E.L., Skibinski D.O., Zair Z.M., Jenkins G.J. Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis. Mutat. Res. 2009, 678:95-100.
37. Junqueira V.B., Koch O.R., Arisi A.C., Fuzaro A.P., Azzalis L.A., Barros S.B., Cravero A., Farre S., Videla L.A. Regression of morphological alterations and oxidative stress-related parameters after acute lindane-induced hepatotoxicity in rats. Toxicology 1997, 117:199-205.
38. Kawata, E., 1992. Personal Communication with Honolulu Board of Water Supply.
39. Kirman C.R., Sweeney L.M., Meek M.E., Gargas M.L. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Regul. Toxicol. Pharmacol. 2003, 38:345-367.
40. Kjellstrand P., Holmquist B., Kanje M., Alm P., Romare S., Jonsson I., Mansson L., Bjerkemo M. Perchloroethylene: effect on body and organ weights and plasma butyrylcholinesterase activity in mice. Acta Pharmacol. Toxicol. 1984, 54:414-424.
41. Kroes R., Wester P.W. Forestomach carcinogens: possible mechanisms of action. Food Chem. Toxicol. 1986, 24:1083-1089.
42. La, D.K., Yen, T.Y., Swenberg, J., 1994. Characterization of DNA adducts induced by 1,2,3-trichloropropane. In: Proceedings of the American Association for Cancer Research Annual Meeting 35, 108. 85th Annual Meeting of the American Association for Cancer Research, San Francisco, CA, April 10-13.
43. La D., Lilly P., Anderegg R., Swenberg J. DNA adduct formation in B6C3F1 mice and Fischer-344 rats exposed to 1,2,3-trichloropropane. Carcinogenesis (Oxford) 1995, 16:1419-1424.
44. La D.K., Schoonhoven R., Ito N., Swenberg J.A. The effects of exposure route on DNA adduct formation and cellular proliferation by 1,2,3-trichloropropane. Toxicol. Appl. Pharmacol. 1996, 140:108-114.
45. La, D.K., Swenberg, J.A., 1997a. The induction of endogenous DNA adducts in tissues of Fischer-344 rats following gavage administration of 1,2,3-trichloropropane. In: Proceedings of the American Association for Cancer Research Annual Meeting 38, 131. 88th Annual Meeting of the American Association for Cancer Research, San Diego, CA, April 12-16.
46. La D.K., Swenberg J.A. Carcinogenic alkylating agents. Chemical Carcinogens and Anticarcinogens 1997, 111-140. Elsevier Science, Oxford. I.G. Sipes, C.A. McQueen, A.J. Gandolfi (Eds.).
47. Longnecker D.S. Interface between adaptive and neoplastic growth in the pancreas. Gut 1987, 28:253-258.
48. Longnecker D.S., Millar P.M. Tumours of the pancreas. Tumours of the Rat 1990, vol. I:241-249. International Agency for Research on Cancer, Lyon. second ed. V.S. Turusov, U. Mohr (Eds.).
49. Lutz W.K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res. 1979, 65:289-356.
50. Lykins Jr., B.W., Baier, J.H., 1985. Removal of Agricultural Contaminants from Ground Water, EPA/600/D-85/136. Environmental Protection Agency, Washington, DC.
51. Maekawa A., Ogiu T., Matsuoka C., Onodera H., Furuta K., Kurokawa Y., Takahashi M., Kokubo T., Tanigawa H., Hayashi Y. Carcinogenicity of low doses of N-ethyl-N-nitrosourea in F344 rats; a dose-response study. Gann 1984, 75:117-125.
52. Mahmood N.A., Burka L.T., Cunningham M.L. Metabolism and mutagenicity of 1,2,3-trichloropropane. Pharmacologist 1988, 30:A8.
53. Mahmood N.A., Overstreet D., Burka L.T. Comparative disposition and metabolism of 1,2,3-trichloropropane in rats and mice. Drug Metab. Dispos. 1991, 19:411-418.
54. Maniere I., Godard T., Doerge D.R., Churchwell M.I., Guffroy M., Laurentie M., Poul J.M. DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide. Mutat. Res. 2005, 580:119-129.
55. Meek M.E., Bucher J.R., Cohen S.M., Dellarco V., Hill R.N., Lehman-McKeeman L.D., Longfellow D.G., Pastoor T., Seed J., Patton D.E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 2003, 33:591-653.
56. Mei N., Hu J., Churchwell M.I., Guo L., Moore M.M., Doerge D.R., Chen T. Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells. Food Chem. Toxicol. 2008, 46:628-636.
57. Merrick B.A., Smallwood C.L., Meier J.R., McKean D.L., Kaylor W.H., Condie L.W. Chemical reactivity, cytotoxicity, and mutagenicity of chloropropanones. Toxicol. Appl. Pharmacol. 1987, 91:46-54.
58. Merrick B.A., Robinson M., Condi L.W. Cardiopathic effect of 1,2,3-trichloropropane after subacute and subchronic exposure in rats. J. Appl. Toxicol. 1991, 11:179-187.
59. Moore M.M., Amtower A., Doerr C., Brock K.H., Dearfield K.L. Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ. Mutagen. 1987, 9:261-267.
60. Nagaya T., Ishikawa N., Hata H., Otobe T. Subclinical and reversible hepatic effects of occupational exposure to trichloroethylene. Int. Arch. Occup. Environ. Health 1993, 64:561-563.
61. National Institute for Occupational Safety and Health (NIOSH), 1981. Trichloropropanes, NTIS PB83-112870.
62. National Research Council (NRC) Risk Assessment in the Federal Government: Managing the Process 1983, National Academy Press, Washington, DC.
63. National Research Council (NRC) Science and Judgement in Risk Assessment 1994, National Academy Press, Washington, DC.
64. National Toxicology Program (NTP), 1990. 1,2,3-Trichloropropane Reproduction and Fertility Assessment in Swiss CD-1 Mice when Administered Via Gavage, NTP 90-209. US Department of Health and Human Services, National Toxicology Program, Research Triangle Park, NC.
65. National Toxicology Program (NTP), 1999. NTP Report on Carcinogens background document for 1,2,3-trichloropropane, Final. Research Triangle Park.
66. National Toxicology Program (NTP), 1993. Toxicology and Carcinogenesis Studies of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies), NTP TR 384. US Department of Health and Human Services, National Toxicology Program, Research Triangle Park, NC.
67. National Toxicology Program (NTP), 1994. Comparative Toxicology Studies of Corn Oil, Safflower Oil, and Tricaprylin (CAS Nos. 8001-30-7, 8001-23-8, and 538-23-8) in Male F344/N Rats as Vehicles for Gavage, NTP TR 426. National Toxicology Program, Research Triangle Park, NC.
68. National Toxicology Program (NTP), 2005. 1,2,3-Trichloropropane. In: Report on Carcinogens, 11th ed. US Department of Health and Human Services.
69. Office of Environmental and Health Hazard Assessment (OEHHA), 2009. Public Health Goal for 1,2,3-Trichloropropane in Drinking Water. Final. California Environmental Protection Agency.
70. Owyang C. Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am. J. Physiol. 1996, 271:G1-G7.
71. Paine M.F., Hart H.L., Ludington S.S., Haining R.L., Rettie A.E., Zeldin D.C. The human intestinal cytochrome P450 " pie" Drug Metab. Dispos. 2006, 34:880-886.
72. Parry J.M., Jenkins G.J., Haddad F., Bourner R., Parry E.M. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds. Mutat. Res. 2000, 464:53-63.
73. Proctor D.M., Gatto N.M., Hong S.J., Allamneni A.P. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol. Sci. 2007, 98:313-326.
74. Ratpan F., Plaumann H. Mutagenicity of halogenated three-carbon compounds and their methylated derivatives. Environ. Mutag. 1985, 7(Suppl 3):15.
75. Rozman K. Influence of dynamics, kinetics, and exposure on toxicity in the lung. Toxicology of the Lung 2006, 195-230. Taylor and Francis, Boca Raton. fourth ed. D.E. Gardner (Ed.).
76. Saito-Suzuki R., Teramoto S., Shirasu Y. Dominant lethal studies in rats with 1,2-dibromo-3-chloropropane and its structurally related compounds. Mutat. Res. 1982, 101:321-327.
77. Sheldon W. Tumours of the Harderian Gland 1994, vol. 111. IARC Sci. Publ., pp. 101-113.
78. Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J.M., Younes M. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 2001, 34:146-152.
79. Swenberg J.A., Fryar-Tita E., Jeong Y.C., Boysen G., Starr T., Walker V.E., Albertini R.J. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem. Res. Toxicol. 2008, 21:253-265.
80. Tafazoli M., Kirsch-Volders M. In vitro mutagenicity and genotoxicity study of 1,2-dichloroethylene, 1,1,2-trichloroethane, 1,3-dichloropropane, 1,2,3-trichloropropane and 1,1,3-trichloropropene, using the micronucleus test and the alkaline single cell gel electrophoresis technique (comet assay) in human lymphocytes. Mutat. Res. 1996, 371:185-202.
81. Tardiff R.G., Gargas M.G., Kirman C.R., Carson M.L., Sweeney L.M. Estimation of safe dietary levels of acrylamide for humans. Food Chem. Toxicol. 2010, 48:658-667.
82. Tomatis L., Aitio A., Wilbourn J., Shuker L. Human carcinogens so far identified. Jpn. J. Cancer Res. 1989, 80:795-807.
83. Torkelson T.R., Oyen F., Rowe V.K. The toxicity of chloroform as determined by single and repeated exposure of laboratory animals. Am. Ind. Hyg. Assoc. J. 1976, 37:697-705.
84. US Environmental Protection Agency (US EPA), 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, EPA/600/8-90/066F. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC.
85. US Environmental Protection Agency (US EPA), 1995. The Use of Benchmark Dose Approach in Health Risk Assessment, EPA/630/R-94/007. Risk Assessment Forum.
86. United States Environmental Protection Agency (US EPA), 2002. A Review of the Reference Dose and Reference Concentration Process, EPA/630/P-02/002F. Final Report.
87. United States Environmental Protection Agency (US EPA), 2005. Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001B.
88. United States Environmental Protection Agency (US EPA), 2006. 2006 Edition of the Drinking Water Standards and Health Advisories, EPA-822-R-06-013.
89. United States Environmental Protection Agency (US EPA), 2009a. Toxicological Review of 1,2,3-Trichloropropane: In Support of Summary Information on the Integrated Risk Information System (IRIS), EPA/635/R-08/010F. Washington, DC.
90. United States Environmental Protection Agency (US EPA), 2009b. Exposure Factors Handbook. 2009 Update. External Review Draft, EPA/600/R-09/052a. Washington, DC.
91. United States 104th Congress, 1996. 1996 Amendments to the Safe Drinking Water Act - Public Law 104-182.
92. Villeneuve D.C., Chu I., Secours V.E., Cote M.G., Plaa G.L., Valli V.E. Results of a 90-day toxicity study on 1,2,3- and 1,1,2-trichloropropane administered via the drinking water. Sci. Total Environ. 1985, 47:421-426.
93. Volp R.F., Sipes I.G., Falcoz C., Carter D.E., Gross J.F. Disposition of 1,2,3-trichloropropane in the Fischer 344 rat: conventional and physiological pharmacokinetics. Toxicol. Appl. Pharmacol. 1984, 75:8-17.
94. Wang E., Wong A., Cortopassi G.A. The rate of mitochondrial mutagenesis is faster in mice than humans. Mutat. Res. 1997, 377:157-166.
95. Weber G.L., Sipes I.G. Covalent interactions of 1,2,3-trichloropropane with hepatic macromolecules: studies in the male F-344 rat. Toxicol. Appl. Pharmacol. 1990, 104:395-402.
96. Weber G.L., Sipes I.G. Rat hepatic DNA damage induced by 1,2,3-trichloropropane. Adv. Exp. Med. Biol. 1991, 283:853-855.
97. Weber G.L., Sipes I.G. In vitro metabolism and bioactivation of 1,2,3-trichloropropane. Toxicol. Appl. Pharmacol. 1992, 113:152-158.
98. Wester P.W., Kroes R. Forestomach carcinogens: pathology and relevance to man. Toxicol. Pathol. 1988, 16:165-170.
99. World Health Organization (WHO) 1,2,3-Trichloropropane. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1995, 63:223-244.
100. World Health Organization (WHO), 2003. 1,2,3 Trichloropropane. Concise International Chemical Assessment Document.
101. World Health Organization (WHO), 2006. Guidelines for Drinking Water Quality, third ed. Geneva.
102. World Health Organization (WHO), 2009. Principles for Modelling Dose-Response for the Risk Assessment of Chemicals. Environmental Health Criteria 239.
103. Zeiger E., Recio L., Fennell T., Haseman J.K., Snyder R.W., Friedman M. Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol. Sci. 2009, 107:247-257.